Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the closing of a common stock financing totaling $10.8...
Read More »NanoView Biosciences Launches EPIC Study to Investigate Impact of Exosome-Associated Biomarkers for Immuno-Oncology
NanoView Biosciences, a leading biomarker characterization company in the emerging field of extracellular vesicle biology, today announced a collaboration agreement with Beth Israel Deaconess...
Read More »Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin
The research team led by Prof. KE Yuehai at the Zhejiang University School of Medicine identified a group of tyrosine phosphatases that regulate the...
Read More »Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into an agreement with Oklahoma State University to evaluate Zofin™ for the treatment of...
Read More »Study focuses on a different kind of liquid biopsy to detect cancer
Because cancer is easier to successfully treat when it's caught early, a major goal in cancer research is to develop new ways to find tumors at early stages, before they start to spread. One approach...
Read More »Codiak presents data demonstrating potential of engineered exosomes
Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics...
Read More »Reopen and Regenerate: Exosome-Coated Stent Heals Vascular Injury, Repairs Damaged Tissue
Researchers from North Carolina State University have developed an exosome-coated stent with a “smart-release” trigger that could both prevent reopened blood vessels from narrowing and deliver regenerative stem cell-derived therapy to blood-starved, or ischemic, tissue. Angioplasty – a procedure that ...
Read More »MDimune and Evercyte form partnership for developing tumor-targeting EVs
MDimune Inc. and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining MDimune’s...
Read More »Novel Strategies to Accelerate Research on Antibodies Against Exosomal Markers
With well-established phage display technology and a professional scientist team providing real-time guidance, Creative Biolabs has released novel exosome antibody development services....
Read More »Extracellular vesicles consumed via honey curb inflammation
Sugars make up about 95% of honey, explaining how the substance became synonymous with sweetness and a food staple of bee colonies, which repeatedly digest and regurgitate flower nectar to produce it. But people have also historically used honey as an ...
Read More »